Faruqi & Faruqi, LLP is investigating claims against Phreesia, Inc. for allegedly misleading investors about slowing demand and reduced revenue visibility, particularly in its pharmaceutical marketing segment. After Phreesia lowered its 2027 revenue guidance on March 30, 2026, its stock dropped 26.56%. Investors who bought Phreesia securities between May 8, 2025, and March 30, 2026, have until July 13, 2026, to seek lead plaintiff status in the class action lawsuit. The law firm encourages affected investors and whistleblowers to come forward to discuss their legal options.
Snow Rothschild Acquisition Corp. priced its initial public offering (IPO) at $200 million, issuing 20 million units at $10 each. Each unit includes one Class A share and half a warrant, allowing purchase of additional shares at $11.50. The units wil...
Piper Sandler downgraded NVIDIA from "Overweight" to "Neutral" citing potential government scrutiny, including concerns over national security and competition. Despite this, demand for NVIDIA's AI products, especially Grace Blackwell systems, is very...
Casey's General Stores is set to report its Q2 2026 earnings on June 9, with analysts forecasting a 28.9% increase in earnings per share to $3.39 and revenue growth of 8.8% to $4.34 billion. Despite a slight 0.8% downward revision in EPS estimates re...
The Law Offices of Frank R. Cruz is investigating Wealthfront Corporation for potential securities fraud following significant financial setbacks. Wealthfront's stock fell sharply after revealing a 69% year-over-year decline in net deposits and a dro...
Mission Produce reported Q2 earnings of one cent per share, missing the analyst estimate of five cents. However, its revenue of $290.9 million beat expectations by 13.5%, though it declined from $380.3 million a year ago. CEO John Pawlowski cited hig...
